SCHEMBL23309543

SCHEMBL23309543

O=C(NC(CO)c1ccccc1)c1cc(F)nc(F)c1F

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR3 P29371 3/20 0.54
▸ MAPK1 P28482 12/20 0.48
▸ PAK4 O96013 2/20 0.47
▸ MAPK13 O15264 1/20 0.47
▸ ROCK2 O75116 1/20 0.47
▸ RPS6KA5 O75582 1/20 0.47
▸ MAP4K4 O95819 1/20 0.47
▸ PRKCG P05129 1/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ PRKACA P17612 1/20 0.47
▸ RPS6KB1 P23443 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ AKT1 P31749 1/20 0.47
▸ AKT2 P31751 1/20 0.47
▸ CLK2 P49760 1/20 0.47
▸ GSK3A P49840 1/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ IRAK1 P51617 1/20 0.47
▸ RPS6KA3 P51812 1/20 0.47
▸ PRKX P51817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30341569 1.00 TACR3 (0.54) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL23309724 0.82 GAA (0.55) TACR3ROCK2ROCK1
SCHEMBL25406737 0.81 MAPK1 (0.51) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL30341785 0.81 MAPK1 (0.51) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL30254858 0.81 MAPK1 (0.51) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL30040770 0.75 TACR3 (0.64) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL25405435 0.74 MAPK1 (0.59) TACR3MAPK1PAK4MAPK13ROCK2
SCHEMBL16679852 0.74 MAPK1 (0.53) TACR3MAPK1PAK4
SCHEMBL16679850 0.74 MAPK1 (0.53) TACR3MAPK1PAK4
SCHEMBL30341563 0.74 MAPK1 (0.59) TACR3MAPK1PAK4MAPK13ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534456-B2 Heterocyclyl pyridines as novel fungicides BAYER AKTIENGESELLSCHAFT (DE) 2026-01-27 — — US disclosed
US-20230295138-A1 HETEROCYCLYL PYRIDINES AS NOVEL FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 2023-09-21 — — US disclosed
CN-116157397-A Heterocyclylpyridines as novel fungicides 拜耳公司 2023-05-23 — — CN disclosed
EP-4161914-A1 HETEROCYCLYL PYRIDINES AS NOVEL FUNGICIDES Bayer Aktiengesellschaft (DE) 2023-04-12 — — EP disclosed
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295138-A1 HETEROCYCLYL PYRIDINES AS NOVEL FUNGICIDES PNPO, CBR3, HPD TACR3 1530/4885MAPK1 1340/4885PAK4 397/4885
US-12534456-B2 Heterocyclyl pyridines as novel fungicides CBR1, CBR3, NOX1 TACR3 1324/4885MAPK1 855/4885PAK4 4717/4885
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL TACR3 4651/4885MAPK1 716/4885PAK4 2175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback